Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy")

American Journal of Emergency Medicine

Volumn 21, Issue 2, 2003, Pages 121-124

  Greene, Shaun L ^a,c   Dargan, Paul I ^a   O'Connor, Niall ^a   Jones, Alison L ^a,b   Kerins, Mary ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c National Poisons Information Service   (United Kingdom)

Author keywords

3,4 methylenedioxymethamphetamine; Case series; Ecstasy; Hyperpyrexia; Serum concentration; Toxicity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; EMERGENCY TREATMENT; FEMALE; GLASGOW COMA SCALE; HUMAN; INTENSIVE CARE; LABORATORY TEST; LIVER FAILURE; MALE; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0037351834     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajem.2003.50028     Document Type: Article

References (32)

1. Jones AL, Dargan PI: Churchill's Textbook of Toxicology. Edinburgh, Churchill Livingstone, 2000, pp 50-52.
2. Peroutka SJ, Newman H, Harris H: Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1988;1:273-277
3. Henry JA, Jeffreys KJ, Dawling S: Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 1992;340:384-387.
4. Dowling GP, McDonough ET, Bost RO: "Eve" and "Ecstasy." A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987;257:1615-1617
5. Brown C, Osterloh J: Multiple severe complications from recreational ingestion of MDMA ("Ecstasy"). JAMA 1987;258:780-781
6. Chadwick IS, Linsley A, Freemount AJ, et al: Ecstasy, 3-4-methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med 1991;84:371
7. Medical Toxicology Unit Analytical Laboratory. National Poisons Information Service, Guys and St Thomas' National Health Service Trust, London, UK, June 2001
8. Metropolitan Police Forensic Science Laboratory. 109 Lambeth Road, London, SE1 7LP, UK
9. Vastag B: Ecstasy experts want realistic messages. JAMA 2001;286:777
10. Gore SM: Fatal uncertainty: death-rate from use of ecstasy or heroin. Lancet 1999;354:1265-1266
11. Ellis AJ, Wendon JA, Portmann B, Williams R: Acute liver damage and ecstasy ingestion. Gut 1996;38:454-458
12. Screaton GR, Singer M, Cairns HS, et al: Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse. Lancet 1992;339(8794):677-678
13. Schmidt CJ, Taylor VL, Abbate GM, Nieduxak TR: 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa: J Pharmacol Exp Ther 1991;256:230-235
14. Gordon CJ, Watkinson WP, O'Callaghan JP, Miller DB: Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav 1991;38:339-344
15. Meterological Office: Bracknell, Berkshire. U.K., Data from the UK meteorological database, 2001
16. Campkin NJ, Davies UM: Treatment of "ecstasy" overdose with dantrolene. Anaesthesia 1993;48:82-83
17. Larner AJ: Dantrolene and "ecstasy" overdose. Anaesthesia 1993;48:179-180
18. Tehan B: Ecstasy and dantrolene. BMJ 1993;306:146
19. Denborough MA, Hopkinson KC: Dantrolene and "ecstasy." Med J Aust 1997;166:165-166
20. Ikemoto T, Hosoya T, Aoyama H, et al: Effects of dantrolene and its derivatives on Ca(2+) release from the sarcoplasmic reticulum of mouse skeletal muscle fibres. Br J Pharmacol 2001;134:729-736
21. Endo M, Yagi S: Mechanism of action of dantrolene sodium, a peripherally acting muscle relaxant. Electroencephalogr Clin Neurophysiol Suppl 1982;36:216-220
22. Andreu V, Mas A, Bruguera M, et al: Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol 1998;29(3):394-397
23. Jones AL, Jarvie DR, McDermid G, Proudfoot AT: Hepatocellular damage following amphetamine intoxication. J Toxicol Clin Toxicol 1994;32:435-444
24. Kew M, Bersohn I, Seftel H, Kent G: Liver damage in heat stroke. Am J M 1970;49:192-202
25. Fidler S, Fagan E, Williams R, et al: Heatstroke and rhabdomyolysis presenting as fulminant hepatic failure. Postgrad Med J 1988;64:157-159
26. Jones AL: Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J Toxicol Clin Toxicol 1998;36:277-285
27. Fahal IH, Sallomi, Yaqoob M, Bell GM: Acute renal failure after ecstasy. BMJ 1992;305:29
28. Foley RJ, Kapatkin K, Verani R, Weinman EJ: Amphetamine-induced acute renal failure. South Med J 1984;77:258-260
29. Randall C, Baselt RC: Disposition of Toxic Drugs and Chemicals in Man. Foster City, CA, Chemical Toxicology Institute, 1995, p 508
30. Chadwick IS, Curry PD, Linsley A, et al: Ecstasy, 3-4-methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med 1991;84:371
31. Brown CR, McKinney H, Osterloh JD, et al: Severe adverse reaction to 3,4-methylenedioxymethamphetamine (MDMA) (abstract). Vet Hum Toxicol 1986;28:490
32. The Mirror, London, UK, June 25, 2001., p 3